CardioRenal Systems secures FDA Breakthrough Device Designation for RenalGuard Therapy
CardioRenal Systems has received the US Food and Drug Administration (FDA) Breakthrough Device Designation for its RenalGuard Therapy device to treat a type of kidney disease. The device